SE9903236D0 - Method to obtain microparticles - Google Patents

Method to obtain microparticles

Info

Publication number
SE9903236D0
SE9903236D0 SE9903236A SE9903236A SE9903236D0 SE 9903236 D0 SE9903236 D0 SE 9903236D0 SE 9903236 A SE9903236 A SE 9903236A SE 9903236 A SE9903236 A SE 9903236A SE 9903236 D0 SE9903236 D0 SE 9903236D0
Authority
SE
Sweden
Prior art keywords
polymer
active substance
obtaining microparticles
atomized
emulsified
Prior art date
Application number
SE9903236A
Other languages
English (en)
Swedish (sv)
Inventor
Brita Sjoeblom
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9903236A priority Critical patent/SE9903236D0/xx
Publication of SE9903236D0 publication Critical patent/SE9903236D0/xx
Priority to NZ517525A priority patent/NZ517525A/en
Priority to AU74637/00A priority patent/AU775458B2/en
Priority to AT00963188T priority patent/ATE245022T1/de
Priority to PCT/SE2000/001682 priority patent/WO2001019345A1/en
Priority to ES00963188T priority patent/ES2200933T3/es
Priority to DK00963188T priority patent/DK1214058T3/da
Priority to JP2001522980A priority patent/JP2003509361A/ja
Priority to EP00963188A priority patent/EP1214058B1/de
Priority to DE60003933T priority patent/DE60003933T2/de
Priority to US09/674,043 priority patent/US6753014B1/en
Priority to CA002382005A priority patent/CA2382005A1/en
Priority to US10/851,702 priority patent/US20040219222A1/en
Priority to US11/339,206 priority patent/US20060159756A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Drying Of Solid Materials (AREA)
  • Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
SE9903236A 1999-09-10 1999-09-10 Method to obtain microparticles SE9903236D0 (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE9903236A SE9903236D0 (sv) 1999-09-10 1999-09-10 Method to obtain microparticles
CA002382005A CA2382005A1 (en) 1999-09-10 2000-09-01 Method to obtain microparticles
DK00963188T DK1214058T3 (da) 1999-09-10 2000-09-01 Fremgangsmåde til opnåelse af mikorpartikler
AU74637/00A AU775458B2 (en) 1999-09-10 2000-09-01 Method to obtain microparticles
AT00963188T ATE245022T1 (de) 1999-09-10 2000-09-01 Verfahren zur herstellung von mikropartikeln
PCT/SE2000/001682 WO2001019345A1 (en) 1999-09-10 2000-09-01 Method to obtain microparticles
ES00963188T ES2200933T3 (es) 1999-09-10 2000-09-01 Metodo para obtener microparticulas.
NZ517525A NZ517525A (en) 1999-09-10 2000-09-01 Method to obtain microparticles
JP2001522980A JP2003509361A (ja) 1999-09-10 2000-09-01 微細粒子を得る方法
EP00963188A EP1214058B1 (de) 1999-09-10 2000-09-01 Verfahren zur herstellung von mikropartikeln
DE60003933T DE60003933T2 (de) 1999-09-10 2000-09-01 Verfahren zur herstellung von mikropartikeln
US09/674,043 US6753014B1 (en) 1999-09-10 2000-09-01 Method to obtain microparticles
US10/851,702 US20040219222A1 (en) 1999-09-10 2004-05-20 Method to obtain microparticles
US11/339,206 US20060159756A1 (en) 1999-09-10 2006-01-25 Method to obtain microparticles containing an H+,K+-ATP-ASE inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9903236A SE9903236D0 (sv) 1999-09-10 1999-09-10 Method to obtain microparticles

Publications (1)

Publication Number Publication Date
SE9903236D0 true SE9903236D0 (sv) 1999-09-10

Family

ID=20416948

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9903236A SE9903236D0 (sv) 1999-09-10 1999-09-10 Method to obtain microparticles

Country Status (12)

Country Link
US (2) US6753014B1 (de)
EP (1) EP1214058B1 (de)
JP (1) JP2003509361A (de)
AT (1) ATE245022T1 (de)
AU (1) AU775458B2 (de)
CA (1) CA2382005A1 (de)
DE (1) DE60003933T2 (de)
DK (1) DK1214058T3 (de)
ES (1) ES2200933T3 (de)
NZ (1) NZ517525A (de)
SE (1) SE9903236D0 (de)
WO (1) WO2001019345A1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1074923C (zh) 1993-11-19 2001-11-21 詹森药业有限公司 微囊密封的3-哌啶基取代的1,2-苯并异唑类和1,2-苯并异噻唑类
US20060159756A1 (en) * 1999-09-10 2006-07-20 Brita Sjoblom Method to obtain microparticles containing an H+,K+-ATP-ASE inhibitor
SE0100823D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method I to obtain microparticles
US6284283B1 (en) * 1999-10-21 2001-09-04 Alkermes Controlled Therapeutics, Inc. Method of producing sub-micron particles of biologically active agents and uses thereof
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
RU2230556C2 (ru) 1999-10-29 2004-06-20 Эро-Селтик, С.А. Препаративные формы гидрокодона с контролируемым высвобождением
GB0004827D0 (en) * 2000-02-29 2000-04-19 Quadrant Holdings Cambridge Compositions
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US6824822B2 (en) 2001-08-31 2004-11-30 Alkermes Controlled Therapeutics Inc. Ii Residual solvent extraction method and microparticles produced thereby
AU2002227383B2 (en) 2000-10-30 2004-07-08 Euro-Celtique S.A. Controlled release hydrocodone formulations
SE0100822D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method II to obtain microparticles
AU2002366616A1 (en) * 2001-12-10 2003-06-23 Hte Aktiengesellschaft The High Throughput Experimentation Company Production and shaping of shaped bodies by means of low-temperature cooling and drying processes
GB2399084B (en) 2002-07-30 2007-01-31 Univ Liverpool Porous beads and method of production thereof
CN100366249C (zh) * 2002-09-29 2008-02-06 天津帝士力投资控股集团有限公司 一种替莫唑胺控释给药系统
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
AU2004298719B8 (en) * 2003-12-19 2011-04-07 Alk-Abello A/S Cryogranulation and storage method for active pharmaceutical agents
JP4990632B2 (ja) * 2004-01-28 2012-08-01 ユニリーバー・ナームローゼ・ベンノートシヤープ 多孔質材料およびその製造方法
GB0401947D0 (en) 2004-01-28 2004-03-03 Unilever Plc Porous bodies and method of production thereof
GB0401950D0 (en) * 2004-01-28 2004-03-03 Unilever Plc Porous bodies and method of production thereof
US7456254B2 (en) 2004-04-15 2008-11-25 Alkermes, Inc. Polymer-based sustained release device
ES2375802T3 (es) 2004-04-15 2012-03-06 Alkermes Pharma Ireland Limited Dispositivo de liberación sostenida a base de pol�?mero.
ITRM20040539A1 (it) * 2004-11-02 2005-02-02 Mavi Sud S R L Preparati a base di chitina o suoi derivati per uso cosmetico o medico.
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
US8017152B2 (en) * 2005-05-27 2011-09-13 Stratosphere Pharma Ab Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
EP1726299A3 (de) 2005-05-27 2007-04-18 StratoSphere Pharma AB Kerne und Mikrokapsel zur parenteralen Verabreichung sowie Verfahren zu deren Herstellung
EP1942872A2 (de) * 2005-11-04 2008-07-16 Eastman Chemical Company Carboxyalkylcelluloseester zur verabreichung von schwer löslichen pharmazeutischen wirkstoffen
US20080069891A1 (en) * 2006-09-15 2008-03-20 Cima Labs, Inc. Abuse resistant drug formulation
US20080075777A1 (en) * 2006-07-31 2008-03-27 Kennedy Michael T Apparatus and methods for preparing solid particles
DK2049081T3 (da) 2006-08-09 2013-02-25 Intarcia Therapeutics Inc Osmotiske leveringssystemer og stempelarrangementer
US8445018B2 (en) 2006-09-15 2013-05-21 Cima Labs Inc. Abuse resistant drug formulation
GB0707612D0 (en) 2007-04-19 2007-05-30 Stratosphere Pharma Ab Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
ES2402172T3 (es) 2007-04-23 2013-04-29 Intarcia Therapeutics, Inc Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos
EP2240155B1 (de) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
US20100189845A1 (en) * 2009-01-27 2010-07-29 Frito-Lay North America Inc. Flavor Encapsulation and Method Thereof
US9504274B2 (en) 2009-01-27 2016-11-29 Frito-Lay North America, Inc. Methods of flavor encapsulation and matrix-assisted concentration of aqueous foods and products produced therefrom
CN107638562B (zh) 2009-09-28 2022-12-02 精达制药公司 基本稳态药物递送的快速建立和/或终止
JP2013526523A (ja) 2010-05-11 2013-06-24 シマ ラブス インク． メトプロロールを含むアルコール耐性持続放出性経口剤形
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
WO2015065547A1 (en) 2013-10-31 2015-05-07 Cima Labs Inc. Immediate release abuse-deterrent granulated dosage forms
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US10925639B2 (en) 2015-06-03 2021-02-23 Intarcia Therapeutics, Inc. Implant placement and removal systems
BR112018073511A2 (pt) 2016-05-16 2019-03-26 Intarcia Therapeutics, Inc. polipeptídeos seletivos do receptor de glucagon e métodos de uso dos mesmos
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
MX2019008006A (es) 2017-01-03 2019-08-29 Intarcia Therapeutics Inc Metodos que comprenden la administracion continua de un agonista del receptor de glp-1 y la co-administracion de un farmaco.
JP2019131511A (ja) * 2018-01-31 2019-08-08 理研ビタミン株式会社 薬物含有粒子の製造方法
WO2020225773A1 (en) 2019-05-07 2020-11-12 Clexio Biosciences Ltd. Abuse-deterrent dosage forms containing esketamine
US20220062200A1 (en) 2019-05-07 2022-03-03 Clexio Biosciences Ltd. Abuse-deterrent dosage forms containing esketamine

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4845950A (de) * 1971-10-13 1973-06-30
GB1403584A (en) * 1972-05-19 1975-08-28 Beecham Group Ltd Control medicaments
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
JPS61218516A (ja) * 1985-03-25 1986-09-29 Ichimaru Fuarukosu Kk 徐放性マイクロカプセルの製造法
WO1990013285A1 (en) 1989-05-01 1990-11-15 Enzytech, Inc. Process for producing small particles of biologically active molecules
US5017383A (en) * 1989-08-22 1991-05-21 Taisho Pharmaceutical Co., Ltd. Method of producing fine coated pharmaceutical preparation
US5102983A (en) * 1990-04-02 1992-04-07 United States Surgical Corporation Process for preparing foamed, bioabsorbable polymer particles
FR2702968B1 (fr) * 1993-03-23 1995-06-23 Lafon Labor Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation .
AU680727B2 (en) * 1994-02-09 1997-08-07 Kinerton Limited Process for drying a material from solution
CA2230494A1 (en) * 1995-08-31 1997-03-06 Alkermes Controlled Therapeutics Inc. Composition for sustained release of an agent
US6113947A (en) * 1997-06-13 2000-09-05 Genentech, Inc. Controlled release microencapsulated NGF formulation
GB2329124B (en) 1997-09-12 2002-05-08 Hiran Asoka Malinga Ratwatte Method of forming dose units of active agents

Also Published As

Publication number Publication date
US20040219222A1 (en) 2004-11-04
EP1214058B1 (de) 2003-07-16
AU775458B2 (en) 2004-08-05
NZ517525A (en) 2003-08-29
AU7463700A (en) 2001-04-17
ES2200933T3 (es) 2004-03-16
DK1214058T3 (da) 2003-11-03
DE60003933D1 (de) 2003-08-21
DE60003933T2 (de) 2004-06-03
JP2003509361A (ja) 2003-03-11
EP1214058A1 (de) 2002-06-19
US6753014B1 (en) 2004-06-22
ATE245022T1 (de) 2003-08-15
WO2001019345A1 (en) 2001-03-22
CA2382005A1 (en) 2001-03-22

Similar Documents

Publication Publication Date Title
SE9903236D0 (sv) Method to obtain microparticles
DE60022664D1 (de) Herstellungsverfahren von submikrometerwirkstoffpartikeln
NZ335133A (en) Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof for treating cancer
BR0214279A (pt) Composições farmacêuticas em forma particulada
IL153046A (en) Delayed release microspheres for injection and method of preparation
WO2001015734A3 (en) High viscosity liquid controlled delivery system and medical or surgical device
FR2753639B1 (fr) Procede de preparation de microcapsules de matieres actives enrobees par un polymere et nouvelles microcapsules notamment obtenues selon le procede
SE0100823D0 (sv) Method I to obtain microparticles
AR017752A1 (es) Composicion de matriz solida y porosa, metodo para su preparacion y metodo para la liberacion controlada de un agente terapeutico utilizando dichamatriz
DE60027266D1 (de) Vorrichtung zur aufbereitung einer medizinischen flüssigkeit
DK0432232T3 (da) Fremgangsmåde til fremstilling af små partikler af biologisk aktive molekyler
WO2004058218A3 (en) Prefilming atomizer
JP2009519975A5 (de)
ATE556788T1 (de) Herstellung pharmazeutischer wirkstoffpartikel unter verwendung fokussierter akustischer energie
DE60019199D1 (de) Einkapselung von Aktivsubstanzen
GR3018970T3 (en) Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions.
EP0967007A3 (de) Verfahren zur Mikroverkapselung einer festen Substanz
MY142014A (en) A lipase powder, methods for producing the same and use thereof
RS50341B (sr) Veterinarska formulacija za davanje vodo-nerastvornih lekova željenoj životinji kroz sistem za distribuciju vode
CN106236605A (zh) 多孔微球及其制备方法、应用
DE60001096D1 (de) Lipidmembran zusammensetzungen
WO1998020856A3 (de) Wirkstoffhaltige Mikropartikel, diese enthaltende Mittel, deren Verwendung zur ultraschallgesteuerten Freisetzung von Wirkstoffen sowie Verfahren zu deren Herstellung
DE60327310D1 (de) Flüssige trägerformulierungen mit hohem wassergehalt
ATE207437T1 (de) Auflösungssystem für eine wirkstoffhaltige flüssige lösung
DK0868473T3 (da) Fremgangsmåde til fremstilling af et ikke fibrøst materiale